Statement re Amendment of Terms of Options and Grant of Further Options Thomson Reuters




The Directors of DXS International plc, the provider of clinical decision support systems to Clinical Commissioning Groups, GPs, doctors and healthcare professionals are pleased to announce that the following changes have been made to the existing option arrangements for Directors.

In the light of the successful conclusion of the Company's application for Lot 1 approval under GPSoC, and in order to recognise the previous and continuing contribution of the executive directors, the Board has agreed to enhance the current share option schemes for David Immelman, the Chief Executive, and Steven Bauer, the Managing Director by granting additional options and amending the terms of some of the current options.

Amendment of Current Options

Mr Immelman and Mr Bauer currently hold management options exercisable at 13p totalling 1,846,154 which were due to expire on 18th February 2015. The exercise date for these options has now been extended to 30th April 2023 so that they are co-terminous with the performance related options at 25p. The table below sets out the revised position.

No. of Option Shares Original Option Exercise Date Exercise Price New Exercise Date
David Immelman 923,077 18th February 2015 13p 30th April 2023
1,000,000 30th April 2023 20p No change
Steven Bauer 923077 18th February 2015 13p 30th April 2023
1,000,000 30th April 2023 20p No change

New Share Options

In addition to the amendment of the current management options the Board has agreed to issue new options in favour of its key executives, Mr Immelman and Mr Bauer, and to the Chairman, Mr Sutcliffe. The new options are granted at 25p and 55p respectively and have vested immediately.

No. of Option Shares Option Exercise Date Exercise Price
David Immelman 250,000 30th April 2023 25p
250,000 30th April 2023 55p
StevenBauer 250,000 30th April 2023 25p
250,000 30th April 2023 55p
Bob Sutcliffe 900,000 30th April 2023 25p

As a result of the grant of these new options the Directors currently hold the following options over Ordinary Shares in the Company:

  • 1,846,154 unexercised options at 13p;
  • 2,000,000 unexercised options at 20p
  • 1,400,000 unexercised options 25p;
  • 500,000 unexercised options 55p

Assuming that all existing options and warrants in the Company are exercised they would constitute 17.91% of the issued ordinary share capital of the Company as enlarged.

The Directors of DXS International plc accept responsibility for this announcement.

Contact Information:

David Immelman
Wrecclesham House
Wrecclesham Road
GU10 4PS

Tel: 01252 719800

Corporate Adviser:

David Papworth
City & Merchant Limited,
Salisbury House,
29 Finsbury Circus,

Tel: 020 7101 7676

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DXS International plc via Globenewswire